StonvexLoading…
StonvexStonvexStonvexCore line items from CMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.30B | $7.32B | $7.26B | $8.32B |
Operating Income | $1.73B | $1.49B | $1.24B | $1.22B |
Net Income | $1.07B | $1.00B | $887.00M | $837.00M |
EPS (Diluted) | $3.53 | $3.33 | $3.01 | $2.85 |
Total Assets | $39.94B | $35.92B | $33.52B | $31.35B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $509.00M | $103.00M | $227.00M | $164.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $-1.52B |
Shares Outstanding | 306.40M | 298.80M | 294.40M | 291.30M |